Sheppard Robert Brewster, NP

Sheppard Brewster practices at AtlantiCare Regional Medical Center, Mainland Campus - Mammography in Pomona, New Jersey.

Sheppard Brewster's NPI, 1154059293, was assigned on August 8, 2022. Sheppard Brewster holds New Jersey license 26NJ01367900.

Sheppard Brewster's primary practice is AtlantiCare Regional Medical Center, Mainland Campus - Mammography, at 65 Jimmie Leeds Rd., Pomona, NJ 08240. The practice phone is (609) 383-2800.

Sheppard Brewster's primary practice is AtlantiCare Regional Medical Center, Mainland Campus - Mammography in Pomona, New Jersey. Sheppard Brewster is also affiliated with Cooper University Hospital. The medical group on file is AtlantiCare Physician Group. Dmand AI also links Sheppard Brewster to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sheppard Brewster practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Sheppard Brewster's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Sheppard Brewster is licensed in New Jersey.

CMS counts 68 Medicare patients who saw Sheppard Brewster in 2024. The largest group is 75 to 84, with 36 patients. 75% of them have heart failure, and 75% have high blood pressure. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sheppard Brewster's median patient age at 61, with 41% women.

In 2024, Sheppard Brewster wrote 475 Medicare Part D claims for 232 patients. 89% of them were for generic drugs.

Sheppard Brewster accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Sheppard Brewster from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Aimmune Therapeutics, Inc. paid the most, $96.